Balaji Amines Ltd
BALAMINESBalaji Amines Ltd
BALAMINESPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
33.33 | 3.55 | 0.53% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
31.00 | 3.52 | 1.32% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Balaji Amines Limited is a company, which is engaged in the manufacturing of Aliphatic Amines, their derivatives and specialty chemicals. The Company is running a five star hotel, Balaji Sarovar Premiere.
Investor Presentation
View olderÂPeers
Compare with peersÂGujarat Fluorochemicals Ltd
Vinati Organics Ltd
Navin Fluorine International Ltd
Akzo Nobel India Ltd
Aarti Industries Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 645.92 | 679.74 | 873.36 | 947.28 | 940.78 | 1,317.53 | 2,337.60 | 2,370.65 | 1,671.15 | 1,563.45 | ||||||||||
Raw Materials | 330.53 | 347.33 | 460.97 | 541.01 | 497.97 | 615.80 | 1,276.41 | 1,261.20 | 916.25 | 1,230.24 | ||||||||||
Power & Fuel Cost | 62.42 | 57.94 | 76.52 | 84.70 | 95.03 | 125.02 | 209.93 | 237.59 | 169.89 | |||||||||||
Employee Cost | 21.63 | 24.47 | 26.89 | 29.47 | 34.07 | 33.56 | 96.64 | 85.21 | 82.27 | |||||||||||
Selling & Administrative Expenses | 62.50 | 68.97 | 87.59 | 92.51 | 90.89 | 124.20 | 134.52 | 131.58 | 117.33 | |||||||||||
Operating & Other expenses | 39.34 | 22.69 | 27.23 | 1.95 | 37.06 | 39.64 | -17.28 | 30.70 | 32.04 | |||||||||||
EBITDA | 129.50 | 158.34 | 194.16 | 197.64 | 185.76 | 379.31 | 637.38 | 624.37 | 353.37 | 333.21 | ||||||||||
Depreciation/Amortization | 19.38 | 19.71 | 19.29 | 19.55 | 31.62 | 34.41 | 42.00 | 45.57 | 45.37 | 46.75 | ||||||||||
PBIT | 110.12 | 138.63 | 174.87 | 178.09 | 154.14 | 344.90 | 595.38 | 578.80 | 308.00 | 286.46 | ||||||||||
Interest & Other Items | 22.15 | 12.94 | 9.04 | 13.03 | 23.03 | 18.29 | 17.10 | 11.97 | 6.44 | 4.90 | ||||||||||
PBT | 87.97 | 125.69 | 165.83 | 165.06 | 131.11 | 326.61 | 578.28 | 566.83 | 301.56 | 281.56 | ||||||||||
Taxes & Other Items | 30.35 | 43.34 | 52.66 | 47.53 | 26.30 | 88.40 | 209.87 | 241.29 | 96.70 | 79.89 | ||||||||||
Net Income | 57.62 | 82.35 | 113.17 | 117.53 | 104.81 | 238.21 | 368.41 | 325.54 | 204.86 | 201.67 | ||||||||||
EPS | 17.78 | 25.42 | 34.93 | 36.27 | 32.35 | 73.52 | 113.70 | 100.47 | 63.23 | 62.24 | ||||||||||
DPS | 2.00 | 2.20 | 2.60 | 2.80 | 3.20 | 4.00 | 6.00 | 10.00 | 11.00 | 11.00 | ||||||||||
Payout ratio | 0.11 | 0.09 | 0.07 | 0.08 | 0.10 | 0.05 | 0.05 | 0.10 | 0.17 | 0.18 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Balaji Amines Ltd | 32.81 | 3.55 | 0.53% |
Gujarat Fluorochemicals Ltd | 102.61 | 7.52 | 0.07% |
Vinati Organics Ltd | 60.13 | 7.89 | 0.37% |
Navin Fluorine International Ltd | 65.86 | 7.48 | 0.42% |
Price Comparison
Compare BALAMINES with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Balaji Amines Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0338% | Percentage of the fund’s portfolio invested in the stock 0.12% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 142/294 (0) |
DSP Nifty Smallcap250 Quality 50 Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0312% | Percentage of the fund’s portfolio invested in the stock 1.16% | Change in the portfolio weight of the stock over the last 3 months -0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 47/52 (-6) |
SBI Nifty Smallcap 250 Index Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0216% | Percentage of the fund’s portfolio invested in the stock 0.12% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 105/294 (-1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Increasing Dividends
BALAMINES has increased dividends consistently over the last 5 years
Dividend Yield
Current dividend yield is 0.53%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.30 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 4, 2024
Dividend/Share
₹11.00
Ex DateEx Date
Jul 4, 2024
Cash Dividend
Ex DateEx DateJul 3, 2023
Dividend/Share
₹10.00
Ex DateEx Date
Jul 3, 2023
Cash Dividend
Ex DateEx DateJun 21, 2022
Dividend/Share
₹6.00
Ex DateEx Date
Jun 21, 2022
Cash Dividend
Ex DateEx DateJul 29, 2021
Dividend/Share
₹4.00
Ex DateEx Date
Jul 29, 2021
Cash Dividend
Ex DateEx DateJul 30, 2020
Dividend/Share
₹0.60
Ex DateEx Date
Jul 30, 2020
Revenue from operations declined 8.85% year on year (YoY) to Rs 346.88 crore in the quarter ended 30 September 2024. Profit before tax stood at Rs 56.81 crore in September 2024 quarter, registering a growth of 18.33% on YoY basis. Sequentially, the company's net profit and revenue from operations in second quarter of FY25 declined 5.34% and 9.84%, respectively. EBITDA during the quarter stood at Rs 70 crore, down 5.41% as compared to Rs 74 crore in Q1 of FY25. EBITDA margin for Q2FY25 improved to 20% in Q2 FY25 as against 19% reported in the same period a year ago. Total expenses declined 11.8% YoY to Rs 299.26 crore during the quarter. Cost of raw material consumed stood at Rs 221.88 crore (up 16% YoY) while other expenses were at Rs 78.92 crore (down 7.31% YoY) in Q2 FY25. The company's revenue from amines amines derivatives volumes stood at 8,685 MT and specialty chemicals volumes stood at 10,046 MT. Looking ahead, Balaji Amines is proposing to set up a plant for manufacture of N-(N-Butyl) Thiophosphoric Triamide (NBPT) with a capacity of 2500 TPA which will be taken up next Financial Year. Additionally, the company aims to expand its ACN production capacity by setting up a new plant with a 60 MT/day capacity at Unit-III in MIDC, Chincholi. The discussion for transfer of the latest technology (reducing the cost of production) is under final stage and the company may sign the agreement by the end of November 2024. New equipment as per the latest technology will be integrated with the existing ACN plant at Unit-III. In a separate development, Balaji Speciality Chemicals, a subsidiary of Balaji Amines, has planned a major expansion with an investment of approximately Rs 750 c rore. This project will focus on a range of products, including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) in both 30% solution and 100% solid forms, EDTA, EDTA-2Na, Benzyl Cyanide (BnCN), Phenylacetic Acid (PAA), and Tri Ethyl Ortho Formate (TEOF)/Tri Methyl Ortho Formate (TMOF). D. Ram Reddy, managing director, Balaji Amines, said, 'In the Q2 quarter, we reported a revenue of Rs 356 crore, achieving an EBITDA margin of 20%. This marks a 110-basis-point improvement over last quarter, reflecting our focus on higher margin products amid a challenging industry environment. While the broader market experienced pressure in Q2, both the API and agrochemical looks promising over a long term, and we are well-positioned to seize these future opportunities. With our expanded capacities and a sharpened focus on operational efficiency, we are confident in our ability to drive sustainable growth in the coming quarters. Our recent developments demonstrate significant progress in expanding our production capacity. With the successful commencement of Methylamines production at Unit-IV, our total annual installed capacity has increased from 48,000 MT to 88,000 MT across all three units. Additionally, Unit-I and Unit-III have achieved BIS Certification for 'Morpholine,' strengthening our quality standards and making us the only BIS-certified Morpholine manufacturer in India. Projects in Electronic Grade DMC, Propylene Glycol Pharma Grade, and Dimethyl Ether are also advancing well, reflecting our commitment to operational excellence. As we look forward, our strong foundation in core capabilities positions us well to navigate industry dynamics and capture growth opportunities.' Balaji Amines is a leading manufacturer of aliphatic amines in India. Broadly, the company is specialized in manufacturing methyl amines, ethyl amines, derivatives of specialty chemicals and natural product and its business is broadly classified into three segments - amines, specialty chemicals and derivatives. Shares of Balaji Amines declined 1.92% to Rs 1,996.15 on the BSE. Powered by Capital Market - Live
Net profit of Balaji Amines rose 18.06% to Rs 40.98 crore in the quarter ended September 2024 as against Rs 34.71 crore during the previous quarter ended September 2023. Sales declined 8.85% to Rs 346.88 crore in the quarter ended September 2024 as against Rs 380.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales346.88380.54 -9 OPM %17.4914.14 - PBDT68.8158.79 17 PBT56.8148.01 18 NP40.9834.71 18 Powered by Capital Market - Live
Balaji Amines will hold a meeting of the Board of Directors of the Company on 14 November 2024.Powered by Capital Market - Live
Revenue from operations was at Rs 384.75 crore in Q1 FY25, down 17.02% from Rs 463.67 crore recorded in the corresponding quarter previous year. Profit before tax slipped 31.85% year on year to Rs 61.58 crore in the quarter ended 30 June 2024. EBITDA for Q1 FY25 stood at Rs 74 crore, down 28.85% as compared to Rs 104 crore in Q1 FY24. EBITDA margin for Q1FY25 reduced to 19% in Q1 FY25 as against 22% reported in the same period a year ago. Total expense declined 12.57% YoY to Rs 331.28 crore during the quarter. Cost of raw material consumed stood at Rs 193.16 crore (down 31.04% YoY) while employee benefits expenses were at Rs 19.18 crore (up 7.39% YoY) in Q1 FY25. The company's revenue from amines amines derivatives volumes stood at 8,299 MT and specialty chemicals volumes stood at 12,371 MT. On standalone basis, the company's net profit jumped 17.55% to Rs 40.52 crore in Q1 FY25 as against Rs 34.47 crore posted in Q1 FY24. Revenue from operations was at Rs 332.84 crore in Q1FY25, down 1.30% YoY. D. Ram Reddy, Managing Director, Balaji Amines, said, 'During the first quarter of FY25, we achieved a 5% year-on-year increase in volume, however, our top line has been impacted by decrease in realisation led by decrease in Raw material pricing. We are actively managing these challenges and are confident in our ability to navigate through them while maintaining our profitability. The Pharma market is showing encouraging signs of improvement, positioning us well for future growth. Although the Agro Chem market has been slow this quarter, we anticipate improvements in the upcoming quarters as market conditions stabilize. Our capital expenditure projects are progressing as planned. The commissioning of our methylamine plant is on schedule for Q3, and the Dimethyl ether project is expected to be completed by the end of this financial year. These projects are advancing as per the scheduled timelines and are set to significantly enhance our portfolio. Looking ahead, we maintain a positive outlook for long-term opportunities, anticipating growth and increased prospects in the fiscal year 2024-25. We remain dedicated to delivering value to our shareholders and stakeholders through strategic investments and a continued focus on operational excellence.' Balaji Amines is a leading manufacturer of aliphatic amines in India. Broadly, the company is specialized in manufacturing methyl amines, ethyl amines, derivatives of specialty chemicals and natural product and its business is broadly classified into three segments - amines, specialty chemicals and derivatives. Powered by Capital Market - Live
Net profit of Balaji Amines declined 17.90% to Rs 43.29 crore in the quarter ended June 2024 as against Rs 52.73 crore during the previous quarter ended June 2023. Sales declined 17.02% to Rs 384.75 crore in the quarter ended June 2024 as against Rs 463.67 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales384.75463.67 -17 OPM %17.1821.14 - PBDT73.23101.87 -28 PBT61.5890.37 -32 NP43.2952.73 -18 Powered by Capital Market - Live
Balaji Amines will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Balaji Amines gains 3% after subsidiary gets mega project status
Balaji Amines Q2 Results Review - Significant Decline In Revenue Due To Drop In Price Realisation: KRChoksey
Balaji Amines Delays Q1 Results Due To Unavailability Of Management
Investors dump Balaji Amines after delay in Q1 results; stock falls
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.02%, vs industry avg of 6.15%
Increasing Market Share
Over the last 5 years, market share increased from 1.72% to 1.97%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 11.75%, vs industry avg of -1.31%